India Exempts Rare Disease Drugs, Keytruda From Customs Duty - Is It Enough?
India, China Likely Have Largest Numbers Of Rare Disease Patients
India has exempted imports of top-selling oncology drug Merck’s Keytruda from customs duty as also rare disease drugs listed in the National Policy For Rare Diseases. However, patient advocacy groups feel more fiscal measures and manufacturing incentives are needed to improve access
